Track topics on Twitter Track topics that are important to you
DelveInsight's Cytomegalovirus CMV Infection Market Insights, Epidemiology and Market Forecast2023United States Report provides an overview of the disease and market size of the CMV for United States. It also includes historical and forecasted epidemiological data for the CMV Prevalent, Diagnosed and Treatable Cases, CMV Patients among Transplants, Infants Patients at High Risk of CMV and HIV Patients at High Risk of CMV from 20132023.
As per DelveInsight's estimation, the total number of Diagnosed CMV Infection cases in United States is expected to increase at a CAGR of 0.041% to 77,726 cases in 2023. The US market size of Cytomegalovirus CMV infection shall reach to USD 609.88 Million by the end of 2023. The market size for Prophylaxis is expected to grow at a CAGR of 3.71% from 20132023, while the sales for the therapeutic shall increase at a CAGR of 3.55% from the year 20132023.As per DelveInsight's estimation, the US Prophylaxis market is relatively higher than the therapeutic market.
The report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse Forecast model analysis by Publisher team of industry experts.
Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
Marketed information including available prescription drugs.
The Report also covers the detailed historical and forecasted epidemiological data covering United States from 20132023.
It also provides Market size of Cytomegalovirus CMV infection for United States from 2013 and forecasted Market size to 2023.
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...